[Ile5,Trp23]PTHrP-(3-36) (human)



[Ile5,Trp23]PTHrP-(3-36) (human)

S1SS1E2EE2I3II3Q4QQ4L5LL5L6LL6H7HH7D8DD8K9KK9G10GG10K11KK11S12SS12I13II13Q14QQ14D15DD15L16LL16R17RR17R18RR18R19RR19F20FF20W21WW21L22LL22H23HH23H24HH24L25LL25I26II26A27AA27E28EE28I29II29H30HH30T31TT31A32AA32E33EE33I34II34

SMILES None
InChIKey None
Sequence SEIQLLHDKGKSIQDLRRRFWLHHLIAEIHTAEI

Chemical Properties

Hydrogen bond acceptors None
Hydrogen bond donors None
Rotatable bonds None
Molecular weight (Da)

Database connections



No bioactivity data available.

[Ile5,Trp23]PTHrP-(3-36) (human)

S1SS1E2EE2I3II3Q4QQ4L5LL5L6LL6H7HH7D8DD8K9KK9G10GG10K11KK11S12SS12I13II13Q14QQ14D15DD15L16LL16R17RR17R18RR18R19RR19F20FF20W21WW21L22LL22H23HH23H24HH24L25LL25I26II26A27AA27E28EE28I29II29H30HH30T31TT31A32AA32E33EE33I34II34

Drug properties

Molecular type Peptide
Physiological/Surrogate Surrogate
Approved drug No

Distribution across phases (no. indications)

Phase I 0
Phase II 0
Phase III 0
Phase IV 0

Database connections



Compound is not listed as a drug.